A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  • Li, Xun (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


Short titleBEACON-IPF
StatusActive
Effective start/end date26/02/24 → 25/02/29